Gene of the Month: Neuregulin-1 Fusion Positive NSCLC (NRG1+ NSCLC)

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2019.05.015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Neuregulin 1 (NRG1); Disrupted in Schizophrenia 1 (DISC1)

Science-Business eXchange
2010English

Expression and Localization of Neuregulin-1 (Nrg1) and ErbB2/ErbB4 Receptors

International Journal of Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2013English

NSCLC: Zwei Positive Studien Zu PD-L1-Hemmer

Im Focus Onkologie
2015English

P3.13-34 RET Gene, a New Choice for NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

OA02.01 Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Überlebensvorhersage Beim NSCLC

Im Focus Onkologie
2016English

Association Study of Neuregulin 1 Gene With Schizophrenia

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
2003English

Table 1: Potential Target Genes of HOXC6 in NSCLC.

English

OA02.02 Safety and Preliminary Clinical Activity of Ropotrectinib (TPX-0005), a ROS1/TRK/ALK Inhibitor, in Advanced ROS1 Fusion-Positive NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy